JW
James W. Brush
General Partner at Frazier Life Sciences
JW
James W. Brush
General Partner at Frazier Life Sciences
Palo Alto, California
Overview
James W. Brush is a General Partner and Portfolio Manager at Frazier Life Sciences in Palo Alto, California, with a background in mergers & acquisitions and a focus on biopharmaceuticals and cancer. He has successfully invested in companies like Amunix in Series B, leveraging his expertise in financial analysis and clinical research to drive growth in the pharmaceutical and biotech sectors.
Work Experience
General Partner and Portfolio Manager
2016 - Current
Frazier Life Sciences invests globally in private and publicly-traded companies that discover and commercialize biopharmaceuticals.
Consultant
2014 - 2016
BCG Securities focuses on wealth management with high net worth individuals.
Resident in Internal Medicine, Harvard Medical School
2011 - 2014
Beth Israel Deaconess Medical Center is a health care system that brings together academic medical centers and teaching hospitals.
Raised $5,580,652.00 from Parkinson's Foundation, BIRD Foundation, MassAITC, Society to Improve Diagnosis in Medicine and Massachusetts Life Sciences Center.
Research Assistant
2005 - 2007